Skip to content

Self-Compassion and Quality of Life in Nursing Students With Premenstrual Syndrome

The Mediating Role of Self-Compassion in the Association Between Premenstrual Symptom Severity and Premenstrual Syndrome-Specific Quality of Life Among Nursing Students With Premenstrual Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07684638
Enrollment
164
Registered
2026-07-06
Start date
2026-06-26
Completion date
2026-07-15
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual Syndrome, Quality of Life, Self Compassion

Keywords

Premenstrual Syndrome, Quality of life, Self Compassion

Brief summary

Premenstrual syndrome (PMS) is one of the most common menstrual disorders among women of reproductive age and is characterized by recurrent physical, emotional, cognitive, and behavioral symptoms during the late luteal phase of the menstrual cycle. These symptoms may adversely affect academic performance, daily functioning, interpersonal relationships, and quality of life. Although previous studies have demonstrated that greater premenstrual symptom severity is associated with poorer quality of life, the psychological mechanisms underlying this relationship remain unclear. Self-compassion, defined as a compassionate and nonjudgmental attitude toward oneself during times of difficulty, has been identified as a protective psychological factor associated with better emotional well-being and adaptive coping. However, its mediating role in the relationship between premenstrual symptom severity and premenstrual syndrome-specific quality of life has not been adequately investigated. This cross-sectional study aims to examine the association between premenstrual symptom severity and premenstrual syndrome-specific quality of life and to investigate the mediating role of self-compassion among nursing students who meet the study criteria for PMS (Premenstrual Syndrome Scale score ≥110).

Interventions

None listed

Sponsors

Acibadem University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Female nursing students aged 18 to 25 years. * Regular menstrual cycles. * Premenstrual Syndrome Scale (PMSS) total score of 110 or higher, indicating premenstrual syndrome according to the established cut-off value. * Willingness to participate and provide written informed consent.

Exclusion criteria

* Receiving ongoing physician-prescribed pharmacological treatment for premenstrual syndrome (e.g., oral contraceptives, hormonal therapy, or selective serotonin reuptake inhibitors). * Irregular menstrual cycles. * History of chronic medical disease. * History of psychiatric disorders. * Incomplete study questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
Sociodemographic, Menstrual, and Lifestyle CharacteristicsBaselineSociodemographic, menstrual, reproductive, and lifestyle characteristics will be collected using a researcher-developed questionnaire consisting of 20 items. The questionnaire includes information on age, academic year, menstrual history, menstrual pain characteristics, premenstrual syndrome history, analgesic use, sleep characteristics, caffeine consumption, fast-food consumption, sugar intake, and other lifestyle-related factors.
Premenstrual Syndrome Scale (PMSS)BaselinePremenstrual symptom severity will be assessed using the Premenstrual Syndrome Scale (PMSS). The PMSS is a 44-item self-report instrument consisting of nine subscales (depressive affect, anxiety, fatigue, irritability, depressive thoughts, pain, appetite changes, sleep changes, and bloating). Total scores range from 44 to 220, with higher scores indicating greater premenstrual symptom severity. In accordance with the original scale, a total PMSS score of 110 or higher, representing the established cut-off for premenstrual syndrome, will be used as an eligibility criterion for study enrollment.
Premenstrual Syndrome-Specific Quality of Life Scale (PMS-QoL)Within approximately 1 week after baselinePremenstrual syndrome-specific quality of life will be assessed using the Premenstrual Syndrome-Specific Quality of Life Scale (PMS-QoL). The PMS-QoL is a 22-item self-report instrument consisting of three domains: physical well-being, emotional well-being, and social well-being. Higher scores indicate better premenstrual syndrome-specific quality of life.
Self-Compassion Scale (SCS)Within approximately 1 week after baselineSelf-compassion will be assessed using the Self-Compassion Scale (SCS). The SCS is a 26-item self-report instrument comprising six dimensions: self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. Higher scores indicate greater self-compassion.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026